[Diagnostic value of neuropsychological tests in mild cognitive impairment comorbid with Parkinson's disease]

Area of Science:

• Neurology
• Neuroscience
• Cognitive Science

Background:

• Mild cognitive impairment (MCI) affects approximately 25% of Parkinson's disease (PD) patients without dementia.
• PD-MCI is increasingly recognized as a distinct diagnostic entity.
• Previous MCI definitions relied heavily on memory deficits, often adapted from Alzheimer's disease research.

Purpose of the Study:

• To introduce and evaluate the unified diagnostic criteria for MCI in Parkinson's disease (PD-MCI) adopted in 2012.
• To assess the classification of PD-MCI based on cognitive dysfunction profiles rather than solely memory impairment.
• To explore the potential of these criteria for improving diagnosis, monitoring, and therapeutic strategies for PD-MCI.

Main Methods:

• Utilized the 2012 unified diagnostic criteria for PD-MCI.
• Emphasized neuropsychological assessment as the basis for diagnosis.
• Classified PD-MCI into single-domain and multiple-domain categories, moving away from memory-centric definitions.

Main Results:

• The adopted criteria allow for the diagnosis and classification of PD-MCI.
• Classification is based on the profile of cognitive dysfunctions (single-domain vs. multiple-domain), not exclusively memory impairment.
• The criteria aim to improve patient monitoring and offer hope for targeted therapies.

Conclusions:

• The unified criteria represent a significant step in diagnosing and managing cognitive impairment in Parkinson's disease.
• While limitations exist, the criteria are expected to enhance patient monitoring and quality of life.
• Standardized diagnostic criteria are crucial for evaluating neuropsychological tests in neurodegenerative disease research, including PD.